ArticleAging2021

Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways.

Linjuan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.